Skip to main content
Erschienen in: International Urogynecology Journal 4/2016

29.10.2015 | Original Article

Robotic or laparoscopic sacrohysteropexy versus open sacrohysteropexy for uterus preservation in pelvic organ prolapse

Erschienen in: International Urogynecology Journal | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The aim of this study was to compare robotic or laparoscopic sacrohysteropexy (RLSH) and open sacrohysteropexy (OSH) as a surgical treatment for pelvic organ prolapse (POP).

Methods

Among 111 consecutive patients who had undergone sacrohysteropexy for POP, surgical outcomes and postoperative symptoms were compared between the RLSH (n = 54; robotic 14 cases and laparoscopic 40 cases) and OSH (n = 57). groups The medical records of enrolled patients were reviewed retrospectively.

Results

Compared with the OSH group, the RLSH group had shorter operating time (120.2 vs 187.5 min, p < 0.0001), less operative bleeding (median estimated blood loss 50 vs 150 ml; p < 0.0001; mean hemoglobin drop 1.4 vs 2.0 g/dl; p < 0.0001), and fewer postoperative symptoms (13 vs 45.6 %; p < 0.0001). Patients’ overall satisfaction (94.4 vs 91.2 %; p = 0.717) and required reoperation due to postoperative complications (3.7 vs 1.8 %; p = 0.611) did not differ between groups.

Conclusions

RLSH could be a feasible and safe procedure in patients with POP and should be considered as a surgical option that allows preservation of the uterus. Prospective randomized trials will permit the evaluation of potential benefits of RLSH as a minimally invasive surgical approach.
Literatur
4.
Zurück zum Zitat Mothes AR, Radosa MP, Altendorf-Hofmann A, Runnebaum IB (2015) Risk index for pelvic organ prolapse based on established individual risk factors. Arch Gynecol Obstet. doi:10.1007/s00404-015-3863-2 Mothes AR, Radosa MP, Altendorf-Hofmann A, Runnebaum IB (2015) Risk index for pelvic organ prolapse based on established individual risk factors. Arch Gynecol Obstet. doi:10.​1007/​s00404-015-3863-2
5.
Zurück zum Zitat Thys SD, Roovers JP, Geomini PM, Bongers MY (2012) Do patients prefer a pessary or surgery as primary treatment for pelvic organ prolapse. Gynecol Obstet Investig 74:6–12. doi:10.1159/000336634 CrossRef Thys SD, Roovers JP, Geomini PM, Bongers MY (2012) Do patients prefer a pessary or surgery as primary treatment for pelvic organ prolapse. Gynecol Obstet Investig 74:6–12. doi:10.​1159/​000336634 CrossRef
6.
Zurück zum Zitat Nygaard IE, McCreery R, Brubaker L, Connolly A, Cundiff G, Weber AM, Zyczynski H, Network PFD (2004) Abdominal sacral colpopexy: a comprehensive review. Obstet Gynecol 104:805–823CrossRefPubMed Nygaard IE, McCreery R, Brubaker L, Connolly A, Cundiff G, Weber AM, Zyczynski H, Network PFD (2004) Abdominal sacral colpopexy: a comprehensive review. Obstet Gynecol 104:805–823CrossRefPubMed
8.
Zurück zum Zitat Korbly NB, Kassis NC, Good MM, Richardson ML, Book NM, Yip S, Saguan D, Gross C, Evans J, Lopes VV, Harvie HS, Sung VW (2013) Patient preferences for uterine preservation and hysterectomy in women with pelvic organ prolapse. Am J Obstet Gynecol 209:470–e1-6. doi:10.1016/j.ajog.2013.08.003 PubMed Korbly NB, Kassis NC, Good MM, Richardson ML, Book NM, Yip S, Saguan D, Gross C, Evans J, Lopes VV, Harvie HS, Sung VW (2013) Patient preferences for uterine preservation and hysterectomy in women with pelvic organ prolapse. Am J Obstet Gynecol 209:470–e1-6. doi:10.​1016/​j.​ajog.​2013.​08.​003 PubMed
13.
Zurück zum Zitat Jeon MJ, Jung HJ, Choi HJ, Kim SK, Bai SW (2008) Is hysterectomy or the use of graft necessary for the reconstructive surgery for uterine prolapse? Int Urogynecol J Pelvic Floor Dysfunct 19(3):351–355CrossRefPubMed Jeon MJ, Jung HJ, Choi HJ, Kim SK, Bai SW (2008) Is hysterectomy or the use of graft necessary for the reconstructive surgery for uterine prolapse? Int Urogynecol J Pelvic Floor Dysfunct 19(3):351–355CrossRefPubMed
14.
19.
Zurück zum Zitat Demirci F, Ozdemir I, Somunkiran A, Topuz S, Iyibozkurt C, Duras Doyran G, Kemik Gul O, Gul B (2007) Perioperative complications in abdominal sacrocolpopexy and vaginal sacrospinous ligament fixation procedures. Int Urogynecol J Pelvic Floor Dysfunct 18:257–261. doi:10.1007/s00192-006-0134-6 CrossRefPubMed Demirci F, Ozdemir I, Somunkiran A, Topuz S, Iyibozkurt C, Duras Doyran G, Kemik Gul O, Gul B (2007) Perioperative complications in abdominal sacrocolpopexy and vaginal sacrospinous ligament fixation procedures. Int Urogynecol J Pelvic Floor Dysfunct 18:257–261. doi:10.​1007/​s00192-006-0134-6 CrossRefPubMed
21.
Zurück zum Zitat Germain A, Thibault F, Galifet M, Scherrer ML, Ayav A, Hubert J, Brunaud L, Bresler L (2013) Long-term outcomes after totally robotic sacrocolpopexy for treatment of pelvic organ prolapse. Surg Endosc 27:525–529. doi:10.1007/s00464-012-2472-4 CrossRefPubMed Germain A, Thibault F, Galifet M, Scherrer ML, Ayav A, Hubert J, Brunaud L, Bresler L (2013) Long-term outcomes after totally robotic sacrocolpopexy for treatment of pelvic organ prolapse. Surg Endosc 27:525–529. doi:10.​1007/​s00464-012-2472-4 CrossRefPubMed
27.
Zurück zum Zitat van IJsselmuiden MN, Coolen AL, Detollenaere RJ, den Boon J, Bongers M, van de Pol G, Vollebregt A, Radder CM, Deprest J, van Eijndhoven HW (2014) Hysteropexy in the treatment of uterine prolapse stage 2 or higher: a multicenter randomized controlled non-inferiority trial comparing laparoscopic sacrohysteropexy with vaginal sacrospinous hysteropexy (LAVA-trial, study protocol). BMC Womens Health 14:112. doi:10.1186/1472-6874-14-112 CrossRefPubMedPubMedCentral van IJsselmuiden MN, Coolen AL, Detollenaere RJ, den Boon J, Bongers M, van de Pol G, Vollebregt A, Radder CM, Deprest J, van Eijndhoven HW (2014) Hysteropexy in the treatment of uterine prolapse stage 2 or higher: a multicenter randomized controlled non-inferiority trial comparing laparoscopic sacrohysteropexy with vaginal sacrospinous hysteropexy (LAVA-trial, study protocol). BMC Womens Health 14:112. doi:10.​1186/​1472-6874-14-112 CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Detollenaere RJ, den Boon J, Stekelenburg J, IntHout J, Vierhout ME, Kluivers KB, van Eijndhoven HW (2015) Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial. BMJ 351:h3717. doi:10.1136/bmj.h3717 CrossRefPubMedPubMedCentral Detollenaere RJ, den Boon J, Stekelenburg J, IntHout J, Vierhout ME, Kluivers KB, van Eijndhoven HW (2015) Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial. BMJ 351:h3717. doi:10.​1136/​bmj.​h3717 CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Seror J, Yates DR, Seringe E, Vaessen C, Bitker MO, Chartier-Kastler E, Roupret M (2012) Prospective comparison of short-term functional outcomes obtained after pure laparoscopic and robot-assisted laparoscopic sacrocolpopexy. World J Urol 30:393–398. doi:10.1007/s00345-011-0748-2 CrossRefPubMed Seror J, Yates DR, Seringe E, Vaessen C, Bitker MO, Chartier-Kastler E, Roupret M (2012) Prospective comparison of short-term functional outcomes obtained after pure laparoscopic and robot-assisted laparoscopic sacrocolpopexy. World J Urol 30:393–398. doi:10.​1007/​s00345-011-0748-2 CrossRefPubMed
32.
Zurück zum Zitat Wright JD, Ananth CV, Lewin SN, Burke WM, Lu YS, Neugut AI, Herzog TJ, Hershman DL (2013) Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA 309:689–698. doi:10.1001/jama.2013.186 CrossRefPubMed Wright JD, Ananth CV, Lewin SN, Burke WM, Lu YS, Neugut AI, Herzog TJ, Hershman DL (2013) Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA 309:689–698. doi:10.​1001/​jama.​2013.​186 CrossRefPubMed
33.
Zurück zum Zitat Serati M, Bogani G, Sorice P, Braga A, Torella M, Salvatore S, Uccella S, Cromi A, Ghezzi F (2014) Robot-assisted sacrocolpopexy for pelvic organ prolapse: a systematic review and meta-analysis of comparative studies. Eur Urol 66:303–318. doi:10.1016/j.eururo.2014.02.053 CrossRefPubMed Serati M, Bogani G, Sorice P, Braga A, Torella M, Salvatore S, Uccella S, Cromi A, Ghezzi F (2014) Robot-assisted sacrocolpopexy for pelvic organ prolapse: a systematic review and meta-analysis of comparative studies. Eur Urol 66:303–318. doi:10.​1016/​j.​eururo.​2014.​02.​053 CrossRefPubMed
34.
Zurück zum Zitat Pan K, Cao L, Ryan NA, Wang Y, Xu H (2015) Laparoscopic sacral hysteropexy versus laparoscopic sacrocolpopexy with hysterectomy for pelvic organ prolapse. Int Urogynecol J. doi:10.1007/s00192-015-2775-9 Pan K, Cao L, Ryan NA, Wang Y, Xu H (2015) Laparoscopic sacral hysteropexy versus laparoscopic sacrocolpopexy with hysterectomy for pelvic organ prolapse. Int Urogynecol J. doi:10.​1007/​s00192-015-2775-9
35.
Zurück zum Zitat Siddiqui NY, Grimes CL, Casiano ER, Abed HT, Jeppson PC, Olivera CK, Sanses TV, Steinberg AC, South MM, Balk EM, Sung VW, Society of Gynecologic Surgeons Systematic Review Group (2015) Mesh sacrocolpopexy compared with native tissue vaginal repair: a systematic review and meta-analysis. Obstet Gynecol 125:44–55. doi:10.1097/AOG.0000000000000570 CrossRefPubMedPubMedCentral Siddiqui NY, Grimes CL, Casiano ER, Abed HT, Jeppson PC, Olivera CK, Sanses TV, Steinberg AC, South MM, Balk EM, Sung VW, Society of Gynecologic Surgeons Systematic Review Group (2015) Mesh sacrocolpopexy compared with native tissue vaginal repair: a systematic review and meta-analysis. Obstet Gynecol 125:44–55. doi:10.​1097/​AOG.​0000000000000570​ CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Desille-Gbaguidi H, Hebert T, Paternotte-Villemagne J, Gaborit C, Rush E, Body G (2013) Overall care cost comparison between robotic and laparoscopic surgery for endometrial and cervical cancer. Eur J Obstet Gynecol Reprod Biol 171:348–352. doi:10.1016/j.ejogrb.2013.09.025 CrossRefPubMed Desille-Gbaguidi H, Hebert T, Paternotte-Villemagne J, Gaborit C, Rush E, Body G (2013) Overall care cost comparison between robotic and laparoscopic surgery for endometrial and cervical cancer. Eur J Obstet Gynecol Reprod Biol 171:348–352. doi:10.​1016/​j.​ejogrb.​2013.​09.​025 CrossRefPubMed
37.
Zurück zum Zitat Fader AN, Seamon LG, Escobar PF, Frasure HE, Havrilesky LA, Zanotti KM, Secord AA, Boggess JF, Cohn DE, Fowler JM, Skafianos G, Rossi E, Gehrig PA (2012) Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers. Gynecol Oncol 126:180–185. doi:10.1016/j.ygyno.2012.04.028 CrossRefPubMed Fader AN, Seamon LG, Escobar PF, Frasure HE, Havrilesky LA, Zanotti KM, Secord AA, Boggess JF, Cohn DE, Fowler JM, Skafianos G, Rossi E, Gehrig PA (2012) Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers. Gynecol Oncol 126:180–185. doi:10.​1016/​j.​ygyno.​2012.​04.​028 CrossRefPubMed
Metadaten
Titel
Robotic or laparoscopic sacrohysteropexy versus open sacrohysteropexy for uterus preservation in pelvic organ prolapse
Publikationsdatum
29.10.2015
Erschienen in
International Urogynecology Journal / Ausgabe 4/2016
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-015-2869-4

Weitere Artikel der Ausgabe 4/2016

International Urogynecology Journal 4/2016 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.